Today, at 1:00 pm, the company announced its nomination committee for the Annual General Meeting 2019.
This press release was said to contain inside information by including a reference to the EU Market Abuse Regulation.
The company wants to clarify that it did not contain information under the EU Market Abuse Regulation.
17 October 2018
GHP Specialty Care AB (publ)
Queries should be addressed to:
Philip Delborn, CFO, Tel: +46 702 12 52 64
GHP is an internationally active health care provider that operates specialist clinics in a select number of diagnostic areas through the application of a business model that is unique in the health care industry, where leading doctors and medical staff become partners and shareholders. Each clinic specialises in a particular patient group, and this leads to increased efficiency and higher quality. This is the cornerstone of GHP’s business philosophy – “Quality through specialisation”. GHP shares are traded on the Small Cap list of Nasdaq Stockholm under the ticker symbol “GHP”.
GHP Specialty Care AB (publ) | Corp. ID No. 556757-1103
Södra Hamngatan 45 | SE-411 06 Gothenburg | Sweden
Tel +46-31 712 53 00 | Fax +46-31 313 13 21 | www.ghp.se
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
Denna information skickades av Cision http://newsroom.cision.com
Filer att ladda ned:Correction of previously announced press release